NCT06203600 2026-04-17Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialNational Cancer Institute (NCI)Phase 2/3 Recruiting224 enrolled
NCT04310007 2026-04-13Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting117 enrolled